HIV / AIDS in the News

Nearly 20 States Scale Back HIV Medication Programs - U.S. News & World Report

 

Nearly 20 States Scale Back HIV Medication Programs - HealthDay

 

The ‘golden age’ of HIV treatment - The Week

 

HIV Self-testing Market Forecast 2026-2036: Market to Reach USD 971.8 Million by 2036 at 13.6% CAGR - openPR.com

 

Too Afraid to Leave Home: ICE’s Toll on Latino HIV Care - Rewire News Group

 

HIV drug programs face cuts - The Pride LA

 

Autologous neutralizing antibodies and polyfunctional T cells contribute to long-term HIV-1 post-intervention control - Nature

 

Editorial: A race against time on AIDS medications - Orlando Sentinel

 

Telehealth owner sentenced in $56M Medicare fraud; NIH trial cuts HIV incidence by 70% in rural Kenya, Uganda; quarter-sized microneedle skin patch for immune monitoring – Morning Medical Update - Medical Economics

 

HIV drug programs face cuts in over 20 states, national report warns - The Pride LA

 

Lenacapavir: What to know about new HIV prevention injection coming to Nigeria - Premium Times Nigeria

 

Refusing to Stay Silent as Florida Turns Its Back on People With HIV | Opinion - Out South Florida

 

The Global HIV/AIDS Epidemic - KFF

 

Gilead Sciences Arcellx Deal Deepens Oncology Bet And Tests HIV Reliance - Yahoo Finance

 

Early treatment helps protect the brains of people living with HIV - spotlightnsp.co.za

 

Zimbabwe takes a big shot toward an HIV-free future - DW.com

 

National Week of Prayer confronts HIV in Black communities - AFRO American Newspapers

 

New Antibody-Drug Conjugate Blocks HIV Infection - Mirage News

 

New antibody–drug conjugate strategy to block HIV infection - isct.ac.jp

 

[CROI 2026] MedPage Today: Study warns of large increase in new HIV cases in US if Ryan White Program ends - European AIDS Treatment Group

 

FAMU Partners with Duke University on $4.75M NIH HIV Prevention Project - Florida A&M University - FAMU

 

[CROI 2026] aidsmap: People with HIV fare as well as those without it after liver transplants - European AIDS Treatment Group

 

[CROI 2026] aidsmap: Doravirine/islatravir non-inferior to Biktarvy as first-line treatment - European AIDS Treatment Group

 

[CROI 2026] Healio: Very early ART may help children control HIV without treatment - European AIDS Treatment Group

 

States limiting HIV drug access as federal funding plateaus - The Hill

 

doravirine islatravir investigational HIV treatment CROI conference - Infectious Disease Special Edition

 

CD4 Count Risk Factors Severe Mpox Infection - Infectious Disease Special Edition

 

Florida cuts off life-saving HIV medication program to tens of thousands of people - LGBTQ Nation

 

'One2PrEP': Gilead's 1st Yeztugo DTC ad reimagines hit song to highlight biannual dosing - Fierce Pharma

 

Integrating Tobacco Treatment in HIV Care - Yale School of Medicine